# An Exploratory Trial of Ketamine for the Treatment of Rett Syndrome

> **NCT02562820** · PHASE1 · TERMINATED · sponsor: **The Cleveland Clinic** · enrollment: 4 (actual)

## Conditions studied

- Rett Syndrome

## Interventions

- **PROCEDURE:** Intravenous infusion
- **PROCEDURE:** Intravenous infusion

## Key facts

- **NCT ID:** NCT02562820
- **Lead sponsor:** The Cleveland Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-11
- **Primary completion:** 2017-07
- **Final completion:** 2017-07
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** Funding withdrawn
- **Last updated:** 2017-08-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02562820

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02562820, "An Exploratory Trial of Ketamine for the Treatment of Rett Syndrome". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02562820. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*